Ravi Rao
Direktor/Vorstandsmitglied bei DBV TECHNOLOGIES
Aktive Positionen von Ravi Rao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| DBV TECHNOLOGIES | Direktor/Vorstandsmitglied | 19.05.2021 | - |
| Independent Dir/Board Member | 19.05.2021 | - | |
| AUTOLUS THERAPEUTICS PLC | Direktor/Vorstandsmitglied | 01.04.2024 | - |
| The Royal College of Physicians | Corporate Officer/Principal | - | - |
Sitryx Therapeutics Ltd.
 Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01.04.2022 | - |
Karriereverlauf von Ravi Rao
Ehemalige bekannte Positionen von Ravi Rao
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| SWEDISH ORPHAN BIOVITRUM AB | Technik-/Wissenschafts-/F&E-Leiter | 18.08.2020 | 01.01.2022 |
| SPYRE THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 04.11.2019 | 10.08.2020 |
| GSK PLC | Technik-/Wissenschafts-/F&E-Leiter | 01.09.2016 | 01.10.2019 |
| Corporate Officer/Principal | 01.04.2012 | 01.09.2016 | |
| OXFORD BIOMEDICA PLC | Corporate Officer/Principal | 01.03.2022 | - |
Ausbildung von Ravi Rao
| University of Cambridge | Undergraduate Degree |
| Imperial College London | Doctorate Degree |
Statistik
International
| Vereinigtes Königreich | 8 |
| Vereinigte Staaten | 2 |
| Schweden | 2 |
Operativ
| Corporate Officer/Principal | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Director/Board Member | 2 |
Sektoral
| Health Technology | 8 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 6 |
|---|---|
| SPYRE THERAPEUTICS, INC. | Health Technology |
| GSK PLC | Health Technology |
| SWEDISH ORPHAN BIOVITRUM AB | Health Technology |
| DBV TECHNOLOGIES | Health Technology |
| OXFORD BIOMEDICA PLC | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Sitryx Therapeutics Ltd.
Sitryx Therapeutics Ltd. Medical SpecialtiesHealth Technology Sitryx Therapeutics Ltd. Focuses on regulating cell metabolism to develop disease-modifying therapeutics in immuno-oncology and immuno-inflammation. It treats cancer and inflammatory conditions by targeting the metabolism of immune cells. The company was founded by Houman Ashrafian, Paul-Peter Tak, Luke O'Neill, Jonathan Powell, Jeff Rathmell and Michael Rosenblum and is headquartered in London, the United Kingdom. | Health Technology |
